Результаты поиска - Eric J. Lawitz

Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment по Hisham Qosa, Claudia H. M. C. deOliveira, Giovanni Cizza, Eric J. Lawitz, Nicholas Colletti, Jeffrey Wetherington, Edgar D. Charles, Giridhar S. Tirucherai

Connect to this object online.

Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function по Wei Yin, Pranab Mitra, Veronique Copalu, Thomas C. Marbury, Juan Carlos Rondon, Eric J. Lawitz, Valerie Lloyd, Mike Baratta, Mahnaz Asgharnejad, Tom Hui, Yasir Khan

Connect to this object online.